Journal of Endocrinological Investigation

, Volume 41, Issue 5, pp 523–529 | Cite as

Anti-parietal cell antibodies in patients with autoimmune thyroid diseases

  • S. R. R. Utiyama
  • R. S. De Bem
  • T. L. Skare
  • G. A. De Carvalho
  • L. M. Teixeira
  • M. Bertolazo
  • S. O. Ioshii
  • R. Nisihara
Original Article
  • 131 Downloads

Abstract

Background

Autoimmune thyroid disease (ATD) patients may have a higher prevalence of anti-parietal cell antibodies (APCA) than normal population.

Objective

To study the prevalence of APCA in a cohort of ATD patients to know its association with patient’s clinical profile and gastrointestinal complaints.

Methods

APCA was sought for by indirect immunofluorescence test in 243 ATD patients: 136 (55.9%) with Graves’ disease and 107 (44.0%) with Hashimoto’s thyroiditis. A structured questionnaire for gastrointestinal symptoms, previous history of thrombosis, arthralgia and other autoimmune diseases in the patients and their families was applied. Positive and negative APCA individuals were compared. Positive patients were invited to perform upper gastrointestinal endoscopy and biopsy of duodenum segments. Sera from 100 healthy individuals from the same geographic area were used as controls.

Results

APCA was present in 20.1% (49/243) of ATD patients: 21.3% (29/136) in the Graves’ sample and 18.6% (20/107) in the Hashimoto’s sample (p = 0.61). Patients with positive APCA had more anemia (p = 0.03; OR = 2.89; 95% CI = 1.03–8.07) and less heartburn (p = 0.01; OR = 0.4; 95% CI = 0.20–0.83). Among the group of 49 APCA-positive patients, 24 agreed with upper endoscopy and it was found that 54.1% had atrophic gastritis.

Conclusions

There is a high prevalence of positive APCA in ATD patients. APCA are more common in those with anemia and less common in those with complaints of heartburn. Almost half of positive APCA patients had atrophic gastritis.

Keywords

Anti-parietal cells Thyroiditis Autoimmunity 

Notes

Compliance with ethical standards

Conflict of interest

None.

Ethical approval

This study was approved by the local Ethics Research Committee.

Informed consent

All participants signed a written consent.

References

  1. 1.
    Minalyan A, Benhammou JN, Artashesyan A, Lewis MS, Pisegna JR (2017) Autoimmune atrophic gastritis: current perspectives. Clin Exp Gastroenterol 10:19–27CrossRefPubMedPubMedCentralGoogle Scholar
  2. 2.
    Rusak E, Chobot A, Krzywicka A, Wenzlau J (2016) Anti-parietal cell antibodies–diagnostic significance. Adv Med Sci 61:175–179CrossRefPubMedGoogle Scholar
  3. 3.
    Smyk DS, Koutsoumpas AL, Mytilinaiou MG, Rigopoulou EI, Sakkas LI, Bogdanos DP (2014) Helicobacter pylori and autoimmune disease: cause or bystander. World J Gastroenterol 20:613–629CrossRefPubMedPubMedCentralGoogle Scholar
  4. 4.
    Šterzl I, Hrdá P, Matucha P, Čeřovská J, Zamrazil V (2008) Anti-Helicobacter pylori, anti-thyroid peroxidase, anti-thyroglobulin and anti-gastric parietal cells antibodies in Czech population. Physiol Res 57(S1):S135–S141PubMedGoogle Scholar
  5. 5.
    Lahner E, Annibale B (2009) Pernicious anemia: new insights from a gastroenterological point of view. World J Gastroenterol 15:5121–5128CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    Venerito M, Radünz M, Reschke K, Reinhold D, Frauenschläger K, Jechorek D et al (2015) Autoimmune gastritis in autoimmune thyroid disease. Aliment Pharmacol Ther 41:686–693CrossRefPubMedGoogle Scholar
  7. 7.
    Cellini M, Santaguida MG, Virili C, Capriello S, Brusca N, Gargano L et al (2017) Hashimoto’s thyroiditis and autoimmune gastritis. Front Endocrinol (Lausanne) 26:8–92. doi: 10.3389/fendo.2017.00092 (eCollection 2017) Google Scholar
  8. 8.
    Gerenova B, Manolova IM, Tzoneva VI (2013) Clinical significance of auto antibodies to parietal cells in patients with autoimmune thyroid diseases. Folia Med (Plovdiv) 55:26–32Google Scholar
  9. 9.
    Santaguida MG, Virili C, Del Duca SC, Cellini M, Gatto I, Brusca N, De Vito C, Gargano L, Centanni M (2015) Thyroxine softgel capsule in patients with gastric-related T4 malabsorption. Endocrine 49:51–57CrossRefPubMedGoogle Scholar
  10. 10.
    García-García B, GimenoOrna JA, Aguillo GE, AltemirTrallero J, Cabrejas Gómez C, Ilundaín González A et al (2010) Prevalence and predictive factors of parietal cell antibody positivity in autoimmune thyroid disease. Endocrinol Nutr 57:49–53CrossRefPubMedGoogle Scholar
  11. 11.
    Bigazzi PE, Rose NR (1984) Pruebas para anticuerpos contra antigenos tissulares especificos. In: Rose NR, Friedman H (eds) El laboratorio en inmunologia clínica, 2nd edn. Editorial Medica Pan Americana, Buenos Aires, pp 968–979Google Scholar
  12. 12.
    Neumann WL, Coss E, Rugge M, Genta RM (2013) Autoimmune atrophic gastritis-pathogenesis, pathology and management. Nat Rev Gastroenterol Hepatol 10:529–541CrossRefPubMedGoogle Scholar
  13. 13.
    Fallahi P, Ferrari SM, Ruffilli I, Elia G, Biricotti M, Vita R et al (2016) The association of other autoimmune diseases in patients with autoimmune thyroiditis: review of the literature and report of a large series of patients. Autoimmun Rev 15:1125–1128CrossRefPubMedGoogle Scholar
  14. 14.
    Centanni M, Marignani M, Gargano L, Corleto VD, Casini A, DelleFave G et al (1999) Atrophic body gastritis in patients with autoimmune thyroid disease: an underdiagnosed association. Arch Intern Med 159:1726–1730CrossRefPubMedGoogle Scholar
  15. 15.
    Irvine WJ, Cullen DR, Mawhinney H (1974) Natural history of autoimmune achlorhydric atrophic gastritis. A 1–15-year follow-up study. Lancet 2:482–485CrossRefPubMedGoogle Scholar
  16. 16.
    Singer W, Sahay BM (1966) Myasthenia gravis, Hashimoto’s thyroiditis, and pernicious anaemia. Br Med J 1(5492):904CrossRefPubMedPubMedCentralGoogle Scholar
  17. 17.
    Park JY, Lam-Himlin D, Vemulapalli R (2013) Review of autoimmune metaplastic atrophic gastritis. Gastrointest Endosc 77:284–292CrossRefPubMedGoogle Scholar
  18. 18.
    Wu YH, Chang JYF, Wang YP, Wu YC, Chen HM, Sun A (2017) Anemia and hematinic deficiencies in anti-gastric parietal cell antibody-positive and -negative recurrent aphthous stomatitis patients with anti-thyroid antibody positivity. J Formos Med Assoc 116:145–152CrossRefPubMedGoogle Scholar
  19. 19.
    Oh RC, Brown DL (2003) Vitamin B12 deficiency. Am Fam Phys 67:979e86Google Scholar
  20. 20.
    Lopez A, Cacoub P, Macdougall IC, Peyrin-Biroulet L (2016) Iron deficiency anaemia. Lancet 387(10021):907–916CrossRefPubMedGoogle Scholar
  21. 21.
    Wang YP, Lin HP, Chen HM, Kuo YS, Lang MJ, Sun A (2014) Hemoglobin, iron, and vitamin B12 deficiencies and high blood homocysteine levels in patients with anti-thyroid autoantibodies. J Formos Med Assoc 113:155–160CrossRefPubMedGoogle Scholar
  22. 22.
    Sibilla R, Santaguida MG, Virili C, Gargano L, Nardo S, Guardia MD et al (2008) Chronic unexplained anaemia in isolated autoimmune thyroid disease or associated with autoimmune related disorders. Clin Endocrinol (Oxf) 68:640–645CrossRefGoogle Scholar
  23. 23.
    Carabotti M, Lahner E, Esposito G, Sacchi MC, Severi C, Annibale B (2017) Upper gastrointestinal symptoms in autoimmune gastritis: a cross-sectional study. Medicine (Baltimore) 96:e5784CrossRefGoogle Scholar
  24. 24.
    Tozzoli R, Kodermaz G, Perosa AR, Tampoia M, Zucano A, Antico A et al (2010) Autoantibodies to parietal cells as predictors of atrophic body gastritis: a five-year prospective study in patients with autoimmune thyroid diseases. Autoimmun Rev 10:80–83CrossRefPubMedGoogle Scholar
  25. 25.
    Yamanishi S, Iizumi T, Watanabe E, Shimizu M, Kamiya S, Nagata K et al (2006) Implications for induction of autoimmunity via activation of B-1 cells by Helicobacter pylori urease. Infect Immun 74:248–256CrossRefPubMedPubMedCentralGoogle Scholar
  26. 26.
    Lahner E, Virili C, Santaguida MG, Annibale B, Centanni M (2014) Helicobacter pylori infection and drugs malabsorption. World J Gastroenterol 20:10331–10337CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Italian Society of Endocrinology (SIE) 2017

Authors and Affiliations

  • S. R. R. Utiyama
    • 1
    • 6
  • R. S. De Bem
    • 4
  • T. L. Skare
    • 3
  • G. A. De Carvalho
    • 2
  • L. M. Teixeira
    • 2
  • M. Bertolazo
    • 1
  • S. O. Ioshii
    • 1
    • 7
  • R. Nisihara
    • 1
    • 5
  1. 1.Laboratory of Immunopathology, Clinical HospitalFederal University of ParanáCuritibaBrazil
  2. 2.Endocrinology Service, Clinical HospitalFederal University of ParanáCuritibaBrazil
  3. 3.Evangelic University Hospital of CuritibaCuritibaBrazil
  4. 4.Gastroenterology and Endoscopy Service, Clinical HospitalFederal University of ParanáCuritibaBrazil
  5. 5.Department of MedicinePositivo UniversityCuritibaBrazil
  6. 6.Department of Clinical AnalysisFederal University of ParanáCuritibaBrazil
  7. 7.Graduate Program in Health TechnologyPontifical Catholic University of ParanáCuritibaBrazil

Personalised recommendations